Description

Monoclonal antibodies against cytokeratin 19 fragment (CYFRA21-1) are used for the specific detection of soluble cytokeratin fragments in serum and are the preferred tumor marker for non-small cell lung cancer (NSCLC), particularly for squamous cell carcinoma.

Specifications

Product Details
Species	Mouse
Specificity	Specific for CYFRA21-1
Subtype	IgG
Expression Host	Mammalian cell
Molecular Mass	150 kDa
Formulation	Purified, Liquid
Purification	>95%
Buffer	PBS, pH7.4
Storage	For long term storage, the product should be stored at -20°C or lower.
Validity	3 years

Instructions for Use

Dissolve the lyophilized powder in an appropriate sterile buffer in a sterile environment before use.
Prepare and dilute the solution according to experimental requirements to ensure accurate and reproducible results.
Do not mix with other similar products to avoid cross-reactivity and potential interference.

Cautions

• Research Use Only: This product is not suitable for clinical diagnostics or therapeutic applications.

• Preservation: Handle according to instructions to preserve its activity and stability.

• Support: Contact our technical support team if you encounter any issues or questions.

Documents

📄 Download COA

Recombinant CYFRA21-1 mAb